Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Non-cash Items (2016 - 2017)

Ultragenyx Pharmaceutical (RARE) has disclosed Non-cash Items for 2 consecutive years, with $165.3 million as the latest value for Q4 2017.

  • Quarterly Non-cash Items rose 108.88% to $165.3 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $165.3 million through Dec 2017, up 108.88% year-over-year, with the annual reading at $165.3 million for FY2017, 10100.91% up from the prior year.
  • Non-cash Items for Q4 2017 was $165.3 million at Ultragenyx Pharmaceutical, up from $79.1 million in the prior quarter.
  • The five-year high for Non-cash Items was $165.3 million in Q4 2017, with the low at $79.1 million in Q4 2016.